Patent · US Active

Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same

US8962565B2 · kind B2 · utility

11Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2012
Grant dateFeb 24, 2015
Priority date
Expiry dateJan 30, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Peptide compounds of general formula (I) R1-(AA)n-X1—X2—X3-Asp-Leu-Lys-Lys-X4—X5-(AA)p-R2, cosmetic or pharmaceutical compositions comprising at least one peptide compound of general formula (I) in a physiologically acceptable medium, and methods for cosmetic treatment of skin are disclosed. The peptide compounds of general formula (I) were demonstrated to be agents making it possible to influence the pigmentation of the skin and skin appendages, by ensuring optimal transfer of the melanosomes to the keratinocytes, so as to make the skin tone uniform owing to an effect on the SCF/c-Kit signaling pathway. The compounds, compositions, and methods treat or attenuate age-related pigmentation defects and the effects of photoaging on the skin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.